| Literature DB >> 35326862 |
Fauna Herawati1,2, Adinda Dessi Irawati1, Ella Viani1, Nully Andaretha Sugianto1, Nur Laili Rahmatin1, Made Prita Artika1, Sukmawati Eka Bima Sahputri1, Kevin Kantono3, Rika Yulia1, Retnosari Andrajati2, Diantha Soemantri4.
Abstract
Clinical pathways can improve the quality of health services. The effectiveness and impact of implementing clinical pathways are controversial. The preparation of clinical pathways not only enacts therapeutic guidelines but requires mutual agreement in accordance with the roles, duties, and contributions of each profession in the team. This study aimed to investigate the perception of interprofessional collaboration practices and the impact of clinical pathway implementation on collaborative and Defined Daily Dose (DDD) prophylactic antibiotics per 100 bed-days in orthopedic surgery. The Collaborative Practice Assessment Tool (CPAT) questionnaire was used as a tool to measure healthcare' perceptions of collaborative practice. The clinical pathway (CP) in this study was adapted from existing CPs published by the Indonesian Orthopaedic Association (Perhimpunan Dokter Spesialis Orthopaedi dan Traumatologi Indonesia, PABOI) and was commended by local domestic surgeons and orthopedic bodies. We then compared post-implementation results with pre-implementation clinical pathway data using ANCOVA to explore our categorical data and its influence towards CPAT response. ANOVA was then employed for aggregated DDD per 100 bed-days to compare pre and post intervention. The results showed that the relationships among members were associated with the working length. Six to ten years of working had a significantly better relationship among members than those who have worked one to five years. Interestingly, pharmacists' leadership score was significantly lower than other professions. The clinical pathway implementation reduced barriers in team collaboration, improved team coordination and organization, and reduced third-generation cephalosporin use for prophylaxis in surgery (pre: 59 DDD per 100 bed-days; post: 28 DDD per 100 bed-days). This shows that the clinical pathway could benefit antibiotic stewardship in improving antibiotic prescription, therefore reducing the incidence of resistant bacteria.Entities:
Keywords: antibiotic stewardship; antibiotics prophylaxis; clinical pathway; defined daily dose; interprofessional collaborative practice
Year: 2022 PMID: 35326862 PMCID: PMC8944506 DOI: 10.3390/antibiotics11030399
Source DB: PubMed Journal: Antibiotics (Basel) ISSN: 2079-6382
CPAT respondent demography characteristic for Study I (N = 261 − NHUH = 98; NBRPH = 96, NHGH = 67).
| Characteristics | Frequency | Percentage (%) |
|---|---|---|
| Age | ||
| 21–25 years | 25 | 11.36 |
| 26–30 years | 62 | 28.18 |
| 31–35 years | 51 | 23.18 |
| 36–40 years | 27 | 12.27 |
| 41–45 years | 17 | 7.73 |
| >45 years | 38 | 17.27 |
| Gender | ||
| Male | 42 | 19.09 |
| Female | 178 | 80.91 |
| Profession | ||
| Doctor | 29 | 13.18 |
| Pharmacist | 14 | 6.36 |
| Nurse | 87 | 39.55 |
| Midwife | 80 | 36.36 |
| Technician | 10 | 4.55 |
| Work length | ||
| 1–5 years | 71 | 32.27 |
| 6–10 years | 74 | 33.64 |
| >10 years | 75 | 34.09 |
| Experience in collaborative practice | ||
| Yes | 212 | 96.36 |
| No | 8 | 3.64 |
Reported CPAT scores categorized by work length (N = 261 − NHUH = 98; NBRPH = 96, NHGH = 67).
| Work Length | 1–5 Years | 6–10 Years | >10 Years | |
|---|---|---|---|---|
| Relationships among members | <0.001 | 4.228 b | 4.472 a | 4.417 ab |
| Barriers in team collaboration | 0.210 | 3.368 a | 3.615 a | 3.506 a |
| Team relationships with the community | 0.252 | 3.580 a | 3.714 a | 3.853 a |
| Team coordination and organization | 0.698 | 4.253 a | 4.306 a | 4.269 a |
| Decision making and conflict management | 0.684 | 1.835 a | 1.771 a | 1.712 a |
| Leadership | 0.627 | 3.808 a | 3.883 a | 3.830 a |
| Mission, goals, and objectives | 0.294 | 4.008 a | 4.125 a | 4.080 a |
| Patient involvement, responsibility, and autonomy | 0.353 | 3.680 a | 3.829 a | 3.811 a |
a,b means with different letters show the significant effect of work length based on Fisher’s Least Significant Difference (LSD), posthoc grouping based on multiple comparisons.
Reported CPAT scores categorized by profession (N = 261 − NHUH = 98; NBRPH = 96, NHGH = 67).
| Profession | Doctor | Midwife | Nurse | Technician | Pharmacist | |
|---|---|---|---|---|---|---|
| Relationships among members | 0.353 | 4.435 a | 4.470 a | 4.357 a | 4.355 a | 4.244 a |
| Barriers in team collaboration | <0.001 | 3.661 a | 3.808 a | 2.865 b | 3.560 a | 3.589 a |
| Team relationships with the community | 0.053 | 3.911 a | 3.869 a | 3.884 a | 3.291 a | 3.624 a |
| Team coordination and organization | 0.786 | 4.366 a | 4.275 a | 4.280 a | 4.285 a | 4.172 a |
| Decision making and conflict management | 0.414 | 1.855 a | 1.913 a | 1.775 a | 1.661 a | 1.659 a |
| Leadership | <0.001 | 4.144 a | 4.072 a | 4.085 a | 3.152 c | 3.750 b |
| Mission, goals, and objectives | 0.216 | 4.222 a | 4.147 a | 4.139 a | 3.929 a | 3.917 a |
| Patient involvement, responsibility, and autonomy | <0.001 | 4.110 a | 4.068 a | 4.146 a | 2.571 b | 3.971 a |
a,b,c means with different letters show the significant effect of work length based on Fishers Least Significant Difference (LSD), posthoc grouping based on multiple comparisons.
CPAT respondent demography characteristic for Study II (NHUH = 52).
| Characteristics | Frequency | Percentage (%) |
|---|---|---|
| Age | ||
| 21–26 years | 5 | 9.62 |
| 26–31 years | 12 | 23.08 |
| 31–35 years | 19 | 36.54 |
| >35 years | 16 | 30.77 |
| Gender | ||
| Male | 10 | 19.23 |
| Female | 42 | 80.77 |
| Profession | ||
| Doctor specialist | 4 | 7.69 |
| Pharmacist | 7 | 13.46 |
| Nurse | 41 | 78.85 |
| Work length | ||
| 1–5 years | 9 | 17.31 |
| 5–10 years | 20 | 38.46 |
| >10 years | 23 | 44.23 |
| Experience in collaborative practice | ||
| Yes | 46 | 88.46 |
| No | 6 | 11.54 |
Overall perception of interprofessional collaboration practices before and after clinical pathway intervention (NHUH = 52).
| Condition | Pre | Post | Effect Size | |
|---|---|---|---|---|
| Relationships among members | 0.229 | 4.278 a | 4.252 a | - |
| Barriers in team collaboration | <0.001 | 3.112 b | 3.442 a | 0.351 |
| Team relationships with the community | 0.390 | 3.837 a | 3.904 a | - |
| Team coordination and organization | <0.05 | 4.082 a | 4.016 b | 0.104 |
| Decision making and conflict management | 0.159 | 1.885 a | 1.923 a | - |
| Leadership | 0.322 | 4.231 a | 4.238 a | - |
| Mission, goals, and objectives | 0.991 | 4.211 a | 4.211 a | - |
| Patient involvement, responsibility, and autonomy | 0.159 | 4.115 a | 4.269 a | - |
a,b means with different letters show the significant effect of work length based on Fisher’s Least Significant Difference (LSD), posthoc grouping based on multiple comparisons.
Profile of DDD 100 bed-days orthopedic patients.
| NO | ATC Code | Antibiotic Name | Pre | Post | ||
|---|---|---|---|---|---|---|
| DDD | DDD/100 Bed-Days | DDD | DDD/100 Bed-Days | |||
| ORAL | ||||||
| 1 | J01DB05 | Cefadroxil | 533.25 | 32.24 | 75.50 | 17.81 |
| 2 | J01DD08 | Cefixime | 446.00 | 26.96 | 87.25 | 20.58 |
| 3 | J01MA02 | Ciprofloxacin | 101.00 | 6.11 | - | - |
| 4 | J01MA12 | Levofloxacin | 9.00 | 0.54 | - | - |
| PARENTERAL | ||||||
| 1 | J01DD04 | Ceftriaxone | 526.00 | 31.80 | 26.25 | 6.19 |
| 2 | J01DB04 | Cefazolin | 626.67 | 37.89 | 121.50 | 28.66 |
| 3 | JO1GB03 | Gentamicin | 36.27 | 2.19 | - | - |
| 4 | J01DD01 | Cefotaxime | - | - | 4.00 | 0.94 |
| Total oral and parenteral | 2278.18 | 137.73 | 314.5 | 74.18 | ||
| Period | Sept.–Nov. 2020 | Jan. 2021 | ||||
| Number of patients | 337 | 41 | ||||
| Length of stays (days) | 1654 | 424 | ||||